Sonus Pharma Looks Promising
Mike Havrilla (July 10th, 2007) Writes:
Sonus Pharma (SNUS) is on the verge of a major catalyst in the form of pivotal Phase 3 clinical trial results
Tags for this Post:
Biotech, Bladder Cancer, Breast Cancer, cancer, Fda, numbness, ovarian cancer, Paclitaxel, small cell lung cancer, Sonus, Tocosol Paclitaxel, treatment of metastatic breast cancer, tumors
Biotech, Bladder Cancer, Breast Cancer, cancer, Fda, numbness, ovarian cancer, Paclitaxel, small cell lung cancer, Sonus, Tocosol Paclitaxel, treatment of metastatic breast cancer, tumors


![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)
